EUTM file information

019054631

Nxera

July 14, 2024

Trademark Summary

The trademark application Nxera was filed by Nxera Pharma Co., Ltd., a corporation established under the laws of Japan (the "Applicant"). Application under examination.

The application was filed in English (German was selected as the second language).

Change of name and address of the trademark registration was recorded on July 28, 2024. Change of name and address of the trademark registration was recorded on August 1, 2024.

Goods And Services

  • The mark was filed in class 1 with following description of goods:
    1. Chemical products and proteins for manufacturing chemical and biological pharmaceutical products
    2. Chemical products and proteins for the research of chemical and biological pharmaceutical products
    3. Chemical products and proteins for diagnostic use, except medical or veterinary uses
    4. Proteins and Gprotein- coupled receptors for manufacturing pharmaceutical products
    5. Proteins and G-protein -coupled receptors for the research of pharmaceutical products
    6. Chemicals and proteins for chemical and biological drug discovery, lead identification and diagnostics
    7. Proteins and G-protein-coupled receptors for drug discovery purposes
    8. Chemicals and biologicals, including proteins, transmembrane proteins and G proteins, G-protein-coupled receptors, and fragments thereof being sequences of amino acids, for chemical and biological drug discovery, lead identification and diagnostics
    9. Proteins, including transmembrane proteins and G-proteins, G-protein-coupled receptors, and fragments thereof being sequences of amino acids, for use in pharmaceutical research, including, drug discovery purposes.
  • The mark was filed in class 5 with following description of goods:
    1. Pharmaceutical preparations
    2. Medicines
    3. Biological products for medical purposes, namely, G-proteincoupled receptors, transmembrane proteins and parts thereof for use in chemical and biological drug discovery, lead identification, diagnostics and therapeutic purposes
    4. Biological and chemical products for medical use, namely, proteins, G-protein-coupled receptors, modulators of G-protein coupled receptors, transmembrane proteins, G-proteins, antibodies and peptides and parts thereof, for therapeutic purposes
    5. Chemicals, proteins and parts thereof for use in medical diagnostics
    6. Biological products for use in chemical and biological drug discovery, lead identification and diagnostics
    7. Biological products for therapeutic purposes
    8. Biological formulation for developing chemical and biological pharmaceutical products
    9. Biological formulation for identifying lead chemical and biological products
    10. Biological formulation for diagnostic use
    11. Biological formulation for therapeutic use
    12. Proteins and G-protein-coupled receptors for drug discovery purposes
    13. Biologicals and small chemical entities, including proteins, G-protein-coupled receptors, modulators of G-protein coupled receptors, transmembrane proteins, G-proteins, antibodies and peptides for therapeutic purposes
    14. Proteins, Gprotein- coupled receptors, transmembrane proteins, G-proteins, antibodies and peptides for use in medical diagnostics.
  • The mark was filed in class 35 with following description of goods:
    1. Business management, organisation and administration in the field of chemical products, biological products, pharmaceuticals, design and development of drugs, drug discovery
    2. Business management, organisation and administration in the field of research and development services in the pharmaceutical and biopharmaceutical fields, including technologies related to proteins and G-protein-coupled receptors
    3. Retail and wholesale services connected with the sale of pharmaceuticals, biological products and chemical and biological preparations.
  • The mark was filed in class 42 with following description of goods:
    1. Drug and pharmaceutical discovery services
    2. Bio-technology, pharmaceutical, chemical and medical testing, research, development, advice, consultancy and information services
    3. Research and development services in the pharmaceutical and biopharmaceutical fields, including technologies related to proteins and G-protein-coupled receptors
    4. Pharmaceutical research services in chemical and biological drug discovery and development
    5. Research and development services for identifying lead chemical compounds
    6. Examination and research services in medicinal and synthetic chemistry
    7. Research and development services in the creation of libraries or collections of biologicals, chemicals and compounds
    8. Research, creation, development and provision of chemical and biological drug targets for screening purposes
    9. Research, analysis and examination for identification of compounds through automated screening processes
    10. Research and development services in chemical and biological pharmaceutical development
    11. Medical laboratory services
    12. Provision of information, advisory services and consultancy relating to the aforesaid services.
  • The mark was filed in class 44 with following description of goods:
    1. Pharmaceutical services
    2. Pharmaceutical advice and consultancy for medical purposes
    3. Providing information relating to diagnostic, prophylactic and therapeutic properties of pharmaceuticals
    4. Research, creation, development and provision of chemical and biological drug targets for medical screening purposes
    5. All of the aforesaid relating to drug discovery and use of Gprotein- coupled receptors in the design and development of pharmaceutical products.